Skip to main content
Fig. 1 | Cancer Nanotechnology

Fig. 1

From: Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transition

Fig. 1

EMT is associated with DOX resistance in breast cancer cells. A Cell viability in vitro on MCF-7 and MCF-7/ADR cells after treatment with different DOX concentration (1.56 μM-200 μM) for 48 h. B, C The expression of E-cadherin, N-cadherin and Vimentin in MCF-7 and MCF-7/ADR cells was analyzed by Western blotting. D, E The invasion activity of MCF-7 and MCF-7/ADR cells were observed and photographed with 200 × microscope, and the OD value was detected at 570 nm to indirectly reflect the number of cells. N = 3, **p < 0.01, ***p < 0.001

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us